ADMA Biologics ADMA Cash received from option exercises
Cash received from option exercises at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's cash received from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's cash received from option exercises?
- ADMA Biologics (ADMA) reported cash received from option exercises of $588K in Q1 2026.
- How has ADMA Biologics's cash received from option exercises changed year-over-year?
- ADMA Biologics's cash received from option exercises increased by 482.2% year-over-year, from $101K to $588K.
- What does cash received from option exercises mean?
- Represents the cash inflows received from employees or directors when they exercise vested stock options. This metric serves as a source of liquidity and indicates the extent to which equity incentive plans are being utilized.